Creighton University is looking for participants in the following studies involving heart disease:
- PARADIGM-HF: A Comparison of LCZ696 to Enalapril in Patients with Chronic Heart Failure
- PEGASUS-TIMI 54: An Investigational Drug Added to Standard Treatment for Patients Who Have Had a Heart Attack in the Last 3 Years
Confidential Research Hotline (402-280-3200)
Research Personnel are expected to report any known or suspected noncompliant conduct related to research or sponsored program activities conducted and/or approved through Creighton University. The confidential Research Compliance Hotline (402-280-3200) is available for any individual who wishes to remain anonymous and/or has found other available reporting mechanisms to be ineffective. Research Personnel may also address their research compliance-related questions or concerns to Kathy Taggart, Associate Vice President for Research and Compliance, at 402-280-2360.
